卡瑞利珠单抗致反应性毛细血管瘤一例

doi:10.35541/cjd.20200002

Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (10): 904-905.doi: 10.35541/cjd.20200002

• Case Reports • Previous Articles Next Articles

A case of reactive capillary hemangiomas induced by camrelizumab

Liang Ning, Gao Wei, Wu Wei, Guo Shenghua

Department of Dermatology, The Affiliated Changzhou No.2 People′s Hospital of Nanjing Medical University, Changzhou 213000, Jiangsu, China

Received:2020-01-02 Revised:2020-07-24 Online:2021-10-15 Published:2021-09-28
Contact: Guo Shenghua E-mail:czeygsh@163.com

Abstract

Liang Ning, Gao Wei, Wu Wei, Guo Shenghua. A case of reactive capillary hemangiomas induced by camrelizumab[J].Chinese Journal of Dermatology, 2021, 54(10): 904-905.

References ［6］

［1］	Fang W, Yang Y, Ma Y, et al. Camrelizumab （SHR⁃1210） alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single⁃arm, phase 1 trials［J］. Lancet Oncol, 2018,19（10）:1338⁃1350. doi: 10.1016/S1470⁃2045（18）30495⁃9.
［2］	Qin S, Ren Z, Meng Z, et al. Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open⁃label, parallel⁃group, randomised, phase 2 trial［J］. Lancet Oncol, 2020,21（4）:571⁃580. doi: 10.1016/S1470⁃2045（20）30011⁃5.
［3］	Wang F, Qin S, Sun X, et al. Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial［J］. J Hematol Oncol, 2020,13（1）:47. doi: 10.1186/s13045⁃020⁃00886⁃2.
［4］	Finlay W, Coleman JE, Edwards JS, et al. Anti⁃PD1 ′SHR⁃1210′ aberrantly targets pro⁃angiogenic receptors and this polyspecificity can be ablated by paratope refinement［J］. MAbs, 2019,11（1）:26⁃44. doi: 10.1080/19420862.2018.1550321.
［5］	Xu J, Zhang Y, Jia R, et al. Anti⁃PD⁃1 antibody SHR⁃1210 combined with apatinib for advanced hepatocellular carcinoma, gastric, or esophagogastric junction cancer: an open⁃label, dose escalation and expansion study［J］. Clin Cancer Res, 2019,25（2）:515⁃523. doi: 10.1158/1078⁃0432.CCR⁃18⁃2484.
［6］	Lim EH, Kim HR, Im M, et al. Eruptive cherry hemangioma⁃like lesions developing in a patient with multiple myeloma［J］. J Am Acad Dermatol, 2013,68（4）:e137⁃e138. doi: 10.1016/j.jaad.2012. 09.045.

A case of reactive capillary hemangiomas induced by camrelizumab

PDF

PDF (Mobile)

Like

Knowledge

Abstract

Cite this article

share this article

References ［6］

Related Articles 0

Metrics

Comments

Recommended 10